Continued tirzepatide treatment maintains and augments initial weight reduction seen in first 36 weeks
Model Based on Age, Routine Lab Tests Predicts Atherosclerotic CVD Accurately
C-statistics for laboratory models do not differ significantly from those of more complex pooled cohort equations